3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Status
Completed
3
Recruiting
2
Unknown
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
2966
Carcinoma, Renal Cell
882
Urinary Bladder Neoplasms
711
Kidney Neoplasms
457
Breast Neoplasms
408
Neoplasms
390
Neoplasm Metastasis
229
Carcinoma, Non-Small-Cell Lung
229
Lung Neoplasms
216
Ovarian Neoplasms
211
Colorectal Neoplasms
204
Melanoma
195
Carcinoma, Transitional Cell
190
Testicular Neoplasms
171
Pancreatic Neoplasms
142
Sarcoma
129
Head and Neck Neoplasms
121
Colonic Neoplasms
120
Wilms Tumor
119
Uterine Cervical Neoplasms
116
Stomach Neoplasms
98
Neuroblastoma
90
Multiple Myeloma
88
Lymphoma, Non-Hodgkin
86
Esophageal Neoplasms
86
Lymphoma
83
Carcinoma, Hepatocellular
81
Carcinoma, Ovarian Epithelial
80
Recurrence
75
Squamous Cell Carcinoma of Head and Neck
74
Interventions
Tolvaptan
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Polycystic Kidney, Autosomal Dominant
×
Genitourinary
×
Clear all
NCT04363554
2020-04-30
POVA
Regional Hospital Holstebro
Phase NA
Completed
51 enrolled
NCT03803124
2019-01-14
POLY
Regional Hospital Holstebro
Phase 3
Completed
20 enrolled
NCT02134899
2018-12-10
EVERKYSTE
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
3 enrolled